• Bile Acid Metabolism Subtypes Define Prognostic Markers in C

  2026-06-11

  Feng et al. (2026) present a molecular subtyping of colorectal cancer based on bile acid metabolism, identifying CLCA1, UGT2A3, and ZG16 as key markers of immune dysfunction and prognosis. Their integrative approach links metabolic states to the tumor immune microenvironment, refining biomarker discovery and patient stratification.

• Hydroxychloroquine Sulfate for Autoimmune Disease Research W

  2026-06-10

  Hydroxychloroquine Sulfate (SKU B4874) is a synthetic quinoline derivative designed to inhibit autophagy and TLR7/9 signaling in immune cells. It is ideal for aqueous-based protocols in autoimmune disease research, particularly systemic lupus erythematosus and rheumatoid arthritis models. This product should not be used in workflows requiring organic solvents or long-term solution storage.

• HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody: Technic

  2026-06-10

  The HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody provides sensitive and specific detection of rabbit primary antibodies in fluorescence-based assays, addressing common challenges in signal amplification and background minimization. It is recommended for immunofluorescence, immunohistochemistry, and flow cytometry, but not for detection of non-rabbit primaries or use outside the 488 nm excitation range.

• Tamsulosin (C6445): Quantitative Efficacy and Protocol Innov

  2026-06-09

  Explore the quantitative efficacy of Tamsulosin in ureteral stone expulsion and urinary retention prevention. This article uniquely combines meta-analytical insights with advanced protocol guidance, offering researchers novel strategies and deeper context for using Tamsulosin in smooth muscle relaxation studies.

• Hexamethonium Bromide in Neuronal-Type Nicotinic AChR Resear

  2026-06-09

  Hexamethonium Bromide enables precise, reproducible inhibition of neuronal-type nicotinic AChR, making it indispensable for dissecting autonomic nervous system function and sex-dependent hypertension mechanisms. Explore stepwise protocols, troubleshooting, and advanced assay optimization rooted in evidence from recent landmark studies.

• DAT Neuroimaging for Dopaminergic Neuron Maturation in PD Mo

  2026-06-08

  Goggi et al. (2020) demonstrate that dopamine transporter (DAT) neuroimaging enables accurate, non-invasive assessment of dopaminergic neuron maturation after stem cell transplantation in a preclinical Parkinson's disease (PD) model. Their work reveals the strengths and limitations of in vivo PET imaging for validating cell-based therapies, with implications for translational research and regulatory evaluation.

• Novobiocin: Aminocoumarin Antibiotic in Antiviral Workflows

  2026-06-08

  Novobiocin stands out as a dual-action aminocoumarin antibiotic with robust antibacterial, antiparasitic, and antiviral applications. Its validated efficacy against SFTSV and multidrug-resistant bacteria makes it a versatile tool for translational research, offering protocol flexibility and advanced troubleshooting strategies.

• O-GlcNAcylation Rewires Glycolysis in Wnt-Stimulated Bone Fo

  2026-06-07

  This study uncovers how O-GlcNAcylation acts as a critical mediator of Wnt3a-induced bone formation by modulating aerobic glycolysis in osteoblasts. The findings offer new mechanistic insight into bone anabolism and highlight potential metabolic targets for osteoporosis therapies.

• hiPSC-Derived Intestinal Organoids Transform Pharmacokinetic

  2026-06-06

  This study introduces a streamlined protocol for generating human pluripotent stem cell-derived intestinal organoids, providing a physiologically relevant in vitro platform for drug metabolism and absorption research. The organoids display mature intestinal features, including functional CYP enzymes and drug transporter activity, enhancing the fidelity of pharmacokinetic assessments and offering a superior alternative to traditional models.

• 7-Ethyl-10-hydroxycamptothecin: Mechanisms & Benchmarks in C

  2026-06-05

  7-Ethyl-10-hydroxycamptothecin (SN-38) is a potent DNA topoisomerase I inhibitor and apoptosis inducer widely used in advanced colon cancer research. Its dual mechanism—disruption of topoisomerase I and FUBP1 pathways—positions it as a key reference compound for S-phase and G2 cell cycle arrest studies. APExBIO provides a validated, high-purity form (SKU N2133) for robust in vitro workflows.

• Ibrexafungerp Efficacy in Echinocandin-Resistant Candida: In

  2026-06-05

  This study provides the largest targeted assessment of ibrexafungerp (MK 3118) activity against echinocandin-resistant Candida isolates, focusing on the impact of specific FKS mutations on in vitro susceptibility. The findings highlight ibrexafungerp’s retained, but mutation-dependent, antifungal activity—especially in C. albicans—offering actionable data for resistance-driven clinical and research applications.

• Gepotidacin vs. Fluoroquinolones: Mechanistic Insights into

  2026-06-04

  Gibson et al. provide a detailed structural and mechanistic analysis of gepotidacin’s inhibition of Staphylococcus aureus DNA gyrase, revealing a distinctive single-stranded DNA cleavage mechanism. These findings clarify how gepotidacin differs from fluoroquinolone antibiotics and highlight new opportunities for antibiotic design to address resistance.

• BRD4770: Precision G9a Histone Methyltransferase Inhibitor W

  2026-06-04

  BRD4770 offers targeted inhibition of G9a histone methyltransferase, enabling direct modulation of H3K9 methylation and unraveling epigenetic mechanisms in cancer models. This guide delivers actionable protocols, troubleshooting strategies, and translates reference study insights for advanced cancer biology research.

• Lypressin Acetate: Advanced Mechanisms and Clinical Implicat

  2026-06-03

  Explore the multifaceted biology of Lypressin acetate, a vasopressin analog, focusing on its unique receptor selectivity, translational potential, and advanced applications in antidiuretic and antiviral research. This in-depth analysis offers distinct scientific insights and practical assay guidance.

• Benzyl Quinolone Carboxylic Acid in Cognitive Research Workf

  2026-06-03

  Benzyl Quinolone Carboxylic Acid (BQCA) enables highly selective, reproducible modulation of M1 muscarinic acetylcholine receptor signaling—unlocking next-generation workflows for cognitive function and Alzheimer’s disease research. Discover data-driven protocol enhancements, troubleshooting strategies, and the latest insights on signal bias and neuronal activity optimization.

451 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page